Drreddys Laboratories | RDY - Ordinary Share Capital


Drreddys Laboratories reported INR832.57M in Ordinary Share Capital for its fiscal quarter ending in December of 2025.





Ordinary Share Capital Change Date
ANI Pharmaceuticals USD 22.49M 760K Dec/2025
Aurora Cannabis CAD 56.71M 134.13K Dec/2025
Bayer EUR 982.42M 0 Dec/2025
Canopy Growth CAD 368.28M 35.9M Dec/2025
Cipla INR 807.78M 17K Mar/2026
Corcept Therapeutics USD 107.33M 1.36M Mar/2026
Drreddys Laboratories INR 832.57M 53K Dec/2025
GlaxoSmithKline GBP 4.05B 20.6M Mar/2026
Hikma Pharmaceutical USD 221.89M 181.89M Dec/2025
Lonza CHF 68.64M 0 Dec/2025
Novartis USD 1.91B 60K Mar/2026
Pacira USD 39.31M 1.81M Mar/2026
Phibro Animal Health USD 40.48M 0 Dec/2025
Prestige Brands USD 47.32M 765K Dec/2025
Richter Gedeon HUF 182.86M 3.51M Mar/2026
Sun Pharmaceuticals INR 2.4B 0 Mar/2026
Supernus Pharmaceuticals USD 58.04M 582K Mar/2026
Teva Pharmaceutical Industries USD 1.16B 16.72M Mar/2026